Work

Do valsartan, candesartan, amlodipine, bisoprolol, atenolol, metoprolol, and spironolactone share a common metabolic pathway that could explain the patient's adverse effects?

Year: 2026

Type: article

Abstract: Valsartan, candesartan, amlodipine, bisoprolol, atenolol, metoprolol, and spironolactone have varying metabolic pathways, with potential overlap at CYP3A4 for some, which might contribute to adverse effects.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.20792168

Author: Tripdatabase

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7165553817

FWCI:

Cites:

Cited by:

Related to: 10